Annora Pharma FZ-LLC, headquartered in the UAE, is a leading pharmaceutical company dedicated to ensuring access to high-quality, affordable medicines.
As a Hetero company (hetero.com), we leverage the expertise and global presence of Hetero Labs, a recognized leader in Active Pharmaceutical Ingredients (APIs) and generic formulations. With over 30 years of excellence, Hetero operates in more than 140 countries and is a trusted partner to multinational pharmaceutical companies and global procurement organizations. Hetero’s extensive portfolio includes over 300 APIs, 200+ fixed-dose formulations, a robust focus on biosimilars, and a leadership position in Antiretroviral Drugs (ARVs). With a strong emphasis on innovation and quality, Hetero continues to make a profound impact on global healthcare.
Annora Pharma’s product range spans multiple therapeutic categories, including Cardiovascular, Diabetes, Gastroenterology, Respiratory, Neurology, Psychiatry, Antivirals, Nephrology, Immunomodulators, Analgesics, and Anti-infectives. Our manufacturing facilities, backed by approvals from leading regulatory authorities such as USFDA, UKMHRA, GCC approvals and MCC South Africa, adhere to the highest standards of quality and compliance.
At Annora, inspired by our “Promise for a Healthier World,” we are dedicated to transforming healthcare by providing innovative and accessible solutions that enhance patient well-being and quality of life. Together with Hetero, we are committed to Inspiring Human Belief in a Healthier Future.
